{"disease":{"id":"multiple-myeloma-in-combination-with-bortezomib-thalidomide-and-dexamethasone-in-newly-diagnosed-patients-who-are-eligible-for-autologous-stem-cell-transplant.md","name":"multiple myeloma in combination with bortezomib thalidomide and dexamethasone in newly diagnosed patients who are eligible for autologous stem cell transplant.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}